Centre for Innovative Biomedicine and Biotechnology

CIBB is a Research Center of excellence and international reference in the domains of Biomedicine and Biotechnology created by merging CNC and iCBR.

Integrates

Center for Neuroscience and Cell Biology (CNC)

Coimbra Institute for Clinical and Biomedical Research (iCBR, former IBILI)

Leading Portuguese R&D Unit

Excellent

In FCT Evaluations

2013—2017 Publications

0

Publications

0

In top 10% Journals

0

In top 1% Journals

Researchers from

Faculties of Medicine, Pharmacy, Sciences and Economics

Coimbra University Hospitals (CHUC)

Key collaborators from biotech and pharma industry

Close to 600 members

305 integrated PhD-holders

220 early stage researchers

60 supporting technicians/officers

Research-oriented Advanced Training

Participation in 6 PhD Programs

Participation in 7 MSc Programs

European Training Networks (H2020 MSCA‑ETN) — coordination of 2

Highly Internationalized research

50% of publications as

International Collaborations

11 projects

funded by EU


Funding by the ERC, NIH, USA Department of Defense, US Air Force and Marie Curie Programs, among others

Clinicians at CIBB

86 clinicians

In several areas

IP protection and technology transfer

30 patents under PCT, over 10 licensing agreements

10 new spin-offs

Several contract projects

Honours and Prizes

Frontiers in Reproduction Award

Grande Oficial da Ordem do Infante Insignia

4 Santa Casa Awards

Honors and prizes include the Frontiers in Reproduction Award, the Grande Oficial da Ordem do Infante Insignia, and 4 Santa Casa Awards (largest Portuguese prize in neurodegeneration). Several CIBB PIs have leadership roles in major scientific societies in Portugal (e.g. Neuroscience, Biochemistry, Stem Cells & Cell Therapies and Pharmacology) and elsewhere (e.g. Human Genetics, Microbiology, Clinical Investigation and Controlled Release Society).

Outreach and Communication Activities

1130+ news worth

>2.5 million euros in advertising value

Reaching an audience of ca. 33.9 million